Highlights include a marine heatwave forecasting system, a solar panel recycling solution, research into a common women's ...

The EXODUS H-600 offers an automated, scalable approach to exosome isolation, which should reduce hands-on processing and ...

An international team of scientists has potentially detected the very first hint of a dark matter interaction, in what appears to be the most compelling indication of this mysterious invisible ...

The Barwon Health–Deakin University Clinical Trials Alliance is intended to grow a regionally embedded but globally responsive partnership. Drawing on the complementary strengths of Barwon Health and ...

The Therapeutic Goods Administration (TGA) has granted Clinical Trial Approval (CTA) for a CAR-T cell therapy for multiple myeloma, which is the second most common blood cancer worldwide. A blood ...

Lonza has launched the Nebula Absorbance Reader, an absorbance microplate reader that joins the company’s portfolio of optimised instruments for streamlined endotoxin and pyrogen testing.

This is a video of the sod-turning for the Sydney Biomedical Accelerator (SBA), which opens in 2028. A $780 million partnership between the University of Sydney, Sydney Local Health District and the ...

On board the Schmidt Ocean Institute’s R/V Falkor, a Western Australian Museum-led expedition surveyed the deep Cape Range and Cloates submarine canyons, which are located around 1200 km north of ...

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a new ...

Found in historic uranium and rare earth element mine waste in a cluster of historical, abandoned mine shafts located in the rugged Mount Painter area of the northern Flinders Ranges, South Australia, ...

ION, a dedicated, purpose-built commercial life sciences precinct located in Waterloo, has secured its inaugural partners. Scientific technologies and services provider Thermo Fisher Scientific, ...

Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports a rethink of the default treatment for MSSA and PSSA infections. More than one million deaths per year ...